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Abstract
Bacterial persister cells present a growing concern as they inherit the ability to
tolerate high concentrations of antibiotics and repopulate after an antibiotic
treatment leading to chronic diseases. Pseudomonas aeruginosa causes many
human infections including skin infections and those associated with burn
injuries, and implanted medical devices, and are associated with Cystic Fibrosis.
Recently, the Ren Lab developed a novel approach to eliminate persister cells of
P. aeruginosa, including those in biofilms, using low level electric currents. To
evaluate the safety of this method and to better understand how the underlying
elements, this study focused on the cytotoxicity of treatments with low level DCs
to different human cell lines, effects on P. aeruginosa in co-culture with human
cells, and protein expression of P. aeruginosa in response to DC treatments. Four
human cell lines, Lung Cancer 5803, Lung Cancer 5908, Breast Cancer 231, and
Fibroblast cells, were tested for cytotoxicity during DC treatment. Treatment
with 70 μA/cm2 DC with 4.0 μg/mL tobramycin led to a two-log killing of P.
aeruginosa and 90%+ survival of mammalian cells. Consistently, the proteomic
revealed the stress response in P. aerigunosa was induced by DC treatment.
These findings provide new in insight in bacterial control with DCs which will
help further development of this technology.
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1. Introduction
There is an ever increasing concern over the rapid development and spread of
bacteria that are resistant to multiple antibiotics. Such bacteria present a major
threat to of public health and economy. Bacteria can grow both as individual cells
(planktonic) and in multi-cellular communities attached to surfaces, known as
biofilms. The formation of
biofilms provides an ideal
condition for the development
of multi-antibiotic resistant
strains of bacteria. Biofilms
are commonly found on
infected tissues and implanted
medical devices causing
chronic infections in human

Figure 1: The Five Stages of Pseudomonas
aeruginosa growth on biofilms:
Stage 1, early attachment; Stage 2, irreversible
attachment; Stage 3, primary maturation; Stage 4,
secondary maturation; Stage 5, dispersion [3]

bodies with high mortality and morbidity. For some bacterial species, biofilm
formation is critical for survival in hostile environments because the cells benefit
from the protection of a hydrated matrix of protein and polysaccharide. As
exemplified in Figure 1, biofilm formation starts with individual cells irreversibly
attached to a surface followed by microcololony formation, maturation, and
dispersion. These microcolonies are organized with functional heterogeneity to
allow the transfer of nutrients and metabolic wastes[8].
Most antibiotics are unable to penetrate the exopolysaccharide (EPS) matrix to
reach individual cells because the polymeric substances that construct the biofilm

matrix slowing down diffusion. Further evidence points out that the cells in the
inner layers of bofiloms receive less nutrients and are not susceptible to
antibiotics in their nutrient deficient starving state [1,2,5].
Another mechanism of antibiotic tolerance is persister formation. Persister cells
do not die when antibiotics are administered allowing them to remain in the body
until an antibiotic regime has concluded. At this point, persister cells are able to
return to normal cells and grow rapidly causing chronic infections that can lead to
extended hospital stays and potentially death depending on the physical condition
and immunity of the patient [9].
The Gram-negative bacterium, Pseudomonas aeruginosa, can be found in both
natural environments and disease conditions. It is highly versatile because of its
ability to grow under many different conditions and to elevate a variety of stress
responses. Because it is a Gram-negative bacterium, P. aeruginosa has the
presence of an outer membrane made up of some lipopolysaccharides and
proteins that is not present in Gram-positive bacteria. This outer membrane is
important for the study of this bacterium as it helps with the resistance to
antibiotics by halting the diffusion of antibiotic into the cell. P. aeruginosa is an
opportunistic pathogen that infects patients with cystic fibrosis and in persons
with compromised immune systems (i.e. HIV/AIDS). For patients with cystic
fibrosis, P. aeruginosa presents a serious problem because 80% of the population
gets infected by this bacterium [4]. As discussed by Davies JC, P. aeruginosa is
the main pathogen found in lungs of cystic fibrosis patients. It is thought that the
accumulation of mucus in the airways leads to the breakdown of antibacterial

peptides as well as increased bacterial receptors on the membranes of eukaryotic
cells, and a decreased ability to fight against infection due to the lack in essential
molecules such as nitric oxide and glutathione [15].
Like many other pathogenic bacteria, P. aeruginosa can form biofilms and
persister cells, which are tolerant to most, if not all, antibiotics. Recently, the Ren
Lab developed a novel approach to eliminate persister cells of P. aeruginosa,
including those in biofilms, using low level electric currents. Research using the
bioelectric effect originated in the 1950s and has continuously progressed to
include a multitude of areas of research, but research with its advantages when
used against biofilm formation started only in the 1990s.
A phenomenon named, bioelectric effect, was reported by Costerton and coworkers that low level electric fields produced by electric currents can enhance
the efficacy of the antibiotics against bacterial biofilms. Research has shown the
amount of antibiotic required to control biofilm cells decreases in the presence of
electric current. Alternating current (AC) and direct current (DC) have shown to
be effective. This is especially important to fight biofilm infections because it
allows the doses of antibiotics to be reduced to clinically and physiologically
acceptable values. Normally, antibiotics alone are not effective against biofilms
due to their high tolerance, up to 1000 times higher than planktonic cells.
The use of the bioelectric effect has proven to be promising thus far. The use of
DC current alone has shown to 1 log reduction in CFU/mL. This phenomenom
has been tested and proven for P. aeruginosa, Staphylococcus epidermis,
Staphylococcus gordonii, Candida albicans, and Klebsiella pneumonia with

tobramycin, gentamicin, and cycloheximide [6, 7, 14]. The exact mechanism by
which the bioelectric effect enables for a large increase in bacterial killing,
however, is not well understood.
Recently, the Ren Lab reported that low level DCs can also sensitize persister
cells to antibiotics. This study focuses on the killing of planktonic bacteria cells
(PAO1) by the efficacy of combining low level electrical currents with the
antibiotic tobramycin. Further, the study examines the potential cytotoxic effects
of low level electrical currents on representative mammalian cells to determine if
this method can be safely integrated into medical applications. Finally, the last
part of the study aims to gain a better understanding of how extracellular protein
expression changes during electrical treatment of PAO1. By separating cellular
proteins and comparing the protein expression profiles of the control and treated
samples, we expect to obtain new insight into persister control by low-level DCs.
Proteomics allows quantitative comparison of proteins expression under different
conditions. It was hypothesized that EC treatment can induce and repressed
different sets of proteins in P. aeruginosa cells. Thus, by comparing a control
sample (no EC treatment) with an experimental sample (EC treatment), the
physiological changes in cells can be investigated at the protein level.
Great importance is also put on the need to study the cytotoxicity of the EC
treatment on human cells. Although the EC treatment proves to be effective in
the killing of persister cells, it is necessary to prove that there are no significant
effects of EC treatment on human cells. In this study, we characterized the
viability of LC 5908, LC 5803, and BC 231 with treatment of 70 μA/cm2 and 84

μA/cm2. We further tested the killing of P. aeruginosa PAO1 in co-cultures with
tobramycin and 500 μA DC. To my best knowledge, this is the first study to
investigate the cytotoxicity of low level DCs on LC 5908 and LC 5803 cells, to
test the effects of DCs on P. aeruginosa in co-culture with and to compare
protein expression profiles of P. aeruginosa in response to DCs.

2. Materials and Methods
2. 1 DC treatment of human cells in a planktonic suspension
Two experimental groups were studied to determine the effects of an applied
electrical field on varying cultures of mammalian cells. An electrochemical cell
(Figure 3) was created by putting two stainless steel 304 (SS 304) electrodes
inside a cuvette. An Ag/AgCl reference electrode was used to maintain a steady
current load. Two current densities were used to test the effects of DC on cell
viability, 70 µA/cm2 (500µA) and 84
µA/cm2 (600µA). The cell lines tested
were Lung Cancer 5908, Lung Cancer
5803, and Breast Cancer 231 (obtained
from Dr. Jing An at SUNY Upstate
Medical University). Initially fiber blast
cells were also included in the cells, but
issues with cell proliferation led to their
exclusion from the study. All cell lines
were grown in T-flasks, each containing
25mL the phosphate dense Roswell Park
Memorial Institute medium supplemented
with 10% Fetal Bovine Serum (FBS) and

Image 2: Display of how the
bioelectric effect is set up. Cells
are suspended in the cuvette
shown here

1% Glutamine-Penicillin-Streptomycin (GPS) for 7-8 days. The cells are cultured
with 5% CO2 at 37°C and the medium was replenished every 4 days. To harvest
cells, the medium was removed using a pipet and TE buffer containing 0.25%

Trypsin and 0.53mM EDTA added and let sit for 15 minutes to break apart
proteins in the extracellular matrix. The cells were re-suspended in 10mL RPMI
were transferred to a conical tube and centrifuged at 1000 rpm for three minutes.
The suspension was discarded and 0.85% NaCl solution was added to the solution
to re-suspend the cells for testing. For each test, 3 mL of the mixture was put into
a sterile cuvette and the electrochemical cell was assembled using the two SS 304
coupons and an Ag/AgCl reference electrode. The flow of electricity was set and
monitored by the AfterMath Scientific Data Organizer Software (Pine Research
Instrumentation). The program was set to run at the desired current for sixty
minutes. At time zero, twenty minutes, forty minutes, and sixty minutes, 40 µL of
sample was extracted and dyed with 10 µL of Trypan blue. Ten µL of the mixture
was put onto a hemocytometer. A hemocytometer is a special slide used to count
cells in four different grid quadrants. The cell membrane color number and color
were recorded to determine the viability at 20 minute intervals during the onehour treatment.
2.2 Effect of DC on the viability of human cells infected with PA01
Mammalian cells were collected after incubation for 7-8 days and collected with
TE buffer and centrifuged at 1000 rpm for 3 minutes as described above. Cells
were then re-suspended in 0.85% NaCl. Concurrently, P. aeruginosa PA01 cells
were collected from a 25 mL overnight culture by taking 10mL of the culture and
adding it to a 25 mL conical tube. The PA01 were prepared from a 25mL
overnight culture in Luria-Bertani (LB) medium containing 10 g/L yeast extract,
and 10 g/l NaCl [16]. The tube was centrifuged for 10 minutes at 1000rpm. The

supernatant was discarded and the cells were re-suspended in equal amounts of
0.85% NaCl, mixed using a vortex, then centrifuged for 10 minutes at 1000 rpm.
This step was then repeated one more time. Using a cuvette with 3 mL 0.85%
NaCl buffer as a reference, the OD600 of the 3mL of the PA01 suspension was
adjusted to reach OD600=0.6 for co-culture experiment. OD or optical density is a
measure of the amount of light absorbed by a suspension. In this case the
suspension contains PA01 and 0.85% NaCl was used as a baseline such that
measuring the OD600 of PA01 does not take into the account the presence of the
buffer. Once the OD600 was measured, the sample was diluted such that an
OD600=0.6 was added to the human cells. Upon infection, a current density of
70µA/cm2 was applied for 1 hour using SS 304 electrodes and an Ag/AgCl
reference electrode to create an electrochemical cell (Figure 3). The Trypan Blue
excision method was used to determine the cell viability of human cells during the
one-hour treatment. Also at twenty minute intervals the number of viable PA01
cells was quantified by counting colony forming unit (CFU). CFU is a technique
to approximate the number of bacterial cells in a sample by diluting and ploting
bacterial cells on agar plates (1.5% agar). The process uses 96 well plates with
the addition of 180µL of 0.85% NaCl into an area of 5x7 wells for each sample.
During testing, 20µL of the solution was put into the 5 wells in the first row. By
pipetting 20µL of this mixture, after mixing, to the second row, the concentration
of bacteria is effectively diluted by a factor of ten. Continual dilutions allow
accurate count of bacterial cells.

2.3 Proteomics
Step 1: Protein sample preparation
To obtain quality 2DE images it is important to know the optimal level of
sonication to break the cells. To do this, P. aeruginosa samples were extracted
and sonicated at the following settings of power and time: 50% 1:30 min, 50%
2:00 min, 50% 3:00 min, 75% 1:30 min, 75% 2:00 min, 75% 3:00 min, 100%
1:30 min, 100% 2:00 min, and 100% 3:00 min. For this test, protein samples
were extracted from the pellet and supernatant to better understand how the
amount of proteins varied with increased sonication. A following test was
conducted with 100% sonication at intervals of 1:00 min, 2:00 min, 3:00 min,
4:00 min, and 5:00 min with the addition of 200 µL of lysis buffer. For
information for extraction techniques refer to Step 1 in part 2.4. Note: for the first
test no lysis buffer was used and the sonication information was not available at
the time of this experiment.
Step 2: 1D gel preparation and running
To make 1D gels, the following recipe is used to make two gels (12%
acrylamide):
Distilled water

5.1 mL

0.5M Tris-HCl, pH 6.8

2.5 mL

10% (w/v) SDS stock

100 µL

Acrylamide/ Bis (40% stock)

975 µL

10% ammonium persulfate

50 µL

Temed

10 µL

Once the gel solution is made it is poured into a cassette then a comb is placed on
top to make the wells for running the proteins. To run the mixture a running
buffer is used. Running buffer is made with glycine (115.2g), Tris (24g), SDS
(4g), and dH2O (qs to 4L). The cassettes run until the bands reach the bottom of
the gels
When loading the individual wells with proteins, each sample is died with
bromophenol blue before addition.
Step 3:1D gel imaging
Gels are imaged on the Molecular Imager Gel Doc XR+ System with Image Lab
Software using a 1D gel imaging protocol.
2.4 Variable protein expression mapping due to electrochemical treatment
Step 1: Protein sample preparation
A control and experimental sample of PA01 were prepared from a 25mL
overnight culture in Luria-Bertani (LB) medium containing 10 g/L tryptone, 5 g/L
yeast extract, and 10 g/l NaCl. Overnight cultures were shaken at 200 rpm and
incubated at 37 °C. Samples were prepared by centrifuging samples at 8,000 rpm
at 4°C, 10 min, and washed with Solution W (KCl [3mM] 22.5mg, KH2PO4
1.5mM] 20.5mg, NaCl [68mM] 400mg, Na H2PO4 [9mM] 108mg, and dH2O
100mL). The process was repeated three times. Samples are mixed by pipetting
(avoid vortexing). The amount of lysis buffer needed is calculated such that the
final protein concentration is between 5-7 mg/mL by the following:
1 OD = 1mg/mL of cell mass
Protein = 55% of cell mass

Ex: 5mL culture with OD=0.6 will have
5mL x 0.6 x 1mg/mL x 55% = 1.65mg protein
The samples are then frozen over dry ice then thawed with running tap water and
a vortex is used to mix for ten seconds. The sonicator is used on the 100% pulse
setting (10 seconds on, 10 seconds off) for two, two and a half minute intervals
with the tubes suspended in ice cold water. Samples are then centrifuged at 13.2k
rpm and 4°C for a minimum of 45 minutes, but preferentially 60+ minutes. The
supernatant is then transferred to a new microcentrifuge tube.
Step 2: Rehyrdation
The rehydration mixture follows for each sample:
Protein sample

42 µL

Soln A

60 µL

Rehydration buffer

298 µL

The mixture is then pipetted into a channel of an Immobile Strip Tray plate. After
an Immobile DryStrip is placed gel side down, the protective peel is taken off and
it is cut to fit the tray. Ensure optimal absorption of protein by pushing out any
air bubbles under the strip. The addition of ~1.5mL of mineral oil on top of the
strip prevents the strip from drying. The strips must remain overnight to incubate.
Step 3: 1-D: IsoElectric Focusing (IEF)
First electrode wicks are placed on top of the wires of the acidic and basic ends of
the Multiphor plate to enable the transfer of electricity from the salts to the gel
strip without direct contact. Immobile DryStrips (Bio-Rad) are then transferred
after letting excess mineral oil drip off and placed gel side up. Addition of ~2mL

is used to cover the strips. Check that the tray is in proper orientation before
running the program on the IEF machine. The program should be set as:
500V, 2 min, rapid
3500V, 24 hr, rapid
50µA/gel
Note: ensure to put into the IEF machine program the number of gels so it reaches
set voltages.
Step 4: Gel Preperation
A large Büchner flask or sidearm flask is used to mix:
Tris

dH2O

PDA

40% acrylamide soln

0% APS

TEMED

1 gel:

22mL

35.82mL 0.2645g

24.78mL

100µL

45µL

2 gels:

44mL

71.64mL 0.528g

49.56mL

165µL

75µL

APS solution is made by diluting 0.05g in 500µL dH2O (for two samples, save the
extra 150uL for each sample for later).
The contents must be added from left to right. Before the addition of 40%
acrylamide solution, the mixture is mixed well. Once the 40% acrylamide
solution is added, the solution is de-gased for 10 minutes under a hood with a
vacuum and a rubber stopper to reduce the presence of volatile acrylamide
monomers. The addition of 10% APS and TEMED are added in a circular
mixture with gentle swirling to initiate polymerization. The solution is poured
into the top of the gel cassettes leaving about 2cm of space from the top. One to
two mL of saturated sec-Butanol is added to top of the gel to create an even gel
matrix. The gel should sit for at least 2 hours to polymerize. Excess APS and
some TEMED are used to polymerize excess solution.

Step 5: 2-D Polyacrylamide Gel Electrophoresis (PAGE)
Upon the completion of 1-D IEF, the machine is unplugged and the tray is drained
of the mineral oil. The gel strips are then transferred onto the Immobile Tray gel
side up adding ~3mL of E1 onto each strip and placing it onto a rocker for fifteen
minutes. After draining E1 from the tray, the strips are washed off with dI H2O,
then ~3mL of E2 is added to each strip and it is put on the rocker for five minutes.
E2 is then drained from the tray. E1 and E2 are made from the same base
solution, Solution C, which follows this recipe:
Urea [6M]

9g

Glycerol

6mL

SDS [2%]

0.5g

0.05M Tris pH6.8

11.75mL

To make E1, 0.12 g DTT [2%] is added to 3 mL of solution C. To make E2,
0.15g of Iodoacetamide [2.5%] and a few grains of bromophenol blue are added
to 3mL of solution C.
Before putting the strips into the glass cassettes, dI H2O is added to the top of the
gel. Strips have to be trimmed in order to properly fit into the cassette by
snipping a portion of the strip from either end. The strip is now softly pushed into
contact with the 2-D gel ensuring the acidic end is on the left side of the gel. To
push the gel in, use a piece of filter paper.
The cassettes are then loaded into the Protean cartridges and ~3L of running
buffer is added ensuring the space between the cassettes is full before pouring the
remaining buffer into the tank. Ensure the liquid buffer is not leaking as leaking

will stop the flow of electricity. Running buffer is made with glycine (115.2g),
Tris (24g), SDS (4g), and dH2O (qs to 4L). The machine was 250 mA. During
the first fifteen minutes, it is checked that there is no leaking, the dye front starts
going down, and bubbles are rising. Dye fronts and amp are checked periodically
until the gel front reaches the bottom of the 2D gel and the machine is turned off.
It is normal if the current drops over time.
Step 6: Gel retrieval, pre-imaging, and imaging
Gels are unloaded and put into trays containing dI H2O by carefully using the
spacers to separate the pieces of glass containing the gel. The gels are then eased
into the water and orbited for five minutes at 42 rpm. The water is then dumped
out and a fixation solution (10% methanol and 7% acetic acid) is added and the
gels are put back onto the orbiter for up to one hour. At this point the fixation
solution is put into a hazardous waste container and Sypro Ruby stain (Bio-Rad)
is added. The trays set on the orbit machine overnight covered in aluminum foil
to prevent ultraviolet radiation from degrading the stain. Finally, a 24 hour
destaining period is recommended with two solution changes using the fixation
solution before the sample is ready to image. For imaging, the Molecular Imager
Gel Doc XR+ System with Image Lab Software was used with a Sypro Ruby
stain protocol.
Step 7: Protein extraction
Using a UV box, gels are imaged so that selected plugs can be extracted from the
gel for analysis. Plugs are chosen by comparison between two different gels. For
this experiment, eight protein gels were chosen. Protein plugs are extracted from

the gels using a One Touch Plus Spotpicker with a 1.5 mm diameter (The Gel
Company) and with disposable tips with floating filter for PDM 1.5 One Touch
Plus sp (The Gel Company). Once the spots are extracted they were put into
microcentrifuge tubes.
Step 8: In-Gel Digestion and Extraction
First the gel pieces are washed by adding 100 µL dI H O and letting sit for 5
2

minutes before discarding the H2O. Next a 100 µL (50:50) mixture of 100 mM
Ammoniumbicarbonate (Sigma) and acetonitrile were added and let sit for 10
minutes before discarding the mixture. After adding 50 µL of acetonitrile and
incubating for 5 minutes at 56 °C. The liquid was discarded and the gel pieces
were opaque and shrunken. Gel pieces were then allowed to dry in a sealed
dessicator for 10 minutes.
The next step is for reduction and alkylation of the protein samples. This step
serves break disulfide bonds. First, 20 µL of 10 mM D,L 1,4 Dithiothreitol
(Acros Organics) in 10 0mM Ammoniumbicarbonate is added to each sample and
incubated for 45 minutes at 56 °C. Microcentrifuge tubes are removed and
allowed to cool to room temperature before adding 20 µL of 55 mM
iodoacetamide (Acros Organics) in 100 mM Ammoniumbicarbonate and
incubated in darkness for one hour. Note: for the 2 steps in reduction and
alkylation make 100 mM Ammoniumbicarbonate solutions then add the D,L 1,4
Dithiothreitol and iodoacetamide in their respective molalities (i.e. for step add 10
mM D,L 1,4 Dithiothreitol to 20 µL of 100 mM Ammoniumbicarbonate). The
washing process was then repeated.

Next, the proteins are enzymatically cut into peptide chains using trypsin. A
trypsin solution is made on ice using 10 ng/µL trypsin in 4 °C 50 mM
Ammoniumbicarbonate with 10% acetonitrile. Each protein is rehydrating using
15 µL of the trypsin solution and incubated for thirty minutes on ice.
Subsequently, 10 µL of 50 mM Ammoniumbicarbonate is added to each protein
then put into a 30 °C water bath overnight. The microcentrifuge tubes are
wrapped in Parafilm (Pechiney Plastic Packaging Company) to ensure that no
water enters.
Lastly, peptides are collected for sequencing by stopping the enzymatic reactions
occurring with the addition of formic acid (Acros Organics) to the final
concentration of 1.0%. The supernatant was removed and saved. Afterward, the
addition of 30 µL of 50% acetonitrile with 5% formic acid to each protein was
allowed to sit for 45 minutes before sonicating at 100% for five minutes. The
supernatant was removed and saved with the previous supernatant. The previous
step was repeated again to ensure maximum collection. Lastly, the addition of 30
µL of 90% acetonitrile with 5% formic acid to each protein was allowed to sit for
5 minutes. The supernatant was removed and added to the other supernatants of
the respective proteins. The supernatants were dried in a dessicator. Samples
were sent to Cornell’s Proteomics and Mass Spectrometry Facility. During initial
drying process two protein plugs were lost due to the variation in air pressure.
2.5 Statistical Analysis
All the data was obtained and compared to multiple results and expressed as
averages +/- standard deviations. One-way ANOVA at a significance of p < 0.05

was performed using Microsoft Excels Data Analysis package. In addition, some
tests were analyized using the two-tail 95% confidence t-test.

3. Results
3. 1 DC treatment of human cells in a planktonic suspension
In order to understand the cytotoxicity of DC treatment, three different human cell
lines were tested in an aqueous solution for one hour with current levels of 500µA
or 600µA (or 70 - 84 µA/cm² DC). The three cell lines used were Lung Cancer
5908, Lung Cancer 5803, and Breast Cancer 231. Figure 4 shows the results of
this test. For cell line BC 231, cell viability was only decreased by 7.19% with 1h
treatment at 70 µA/cm² DC. for 500µA. For cell line LC 5803, cell viability
decreased by 7.83% during with 1h treatment at 70 µA/cm² DC. For cell line LC
5908, cell viability decreased by 9.24% during with 1h treatment at 70 µA/cm²
DC. Overall, the results showed that there is no major toxicity to human cells with
DC treatment at the same DC levels the was found effective against P.
aeruginosa.
The testing with 600µA DC on mammalian cells showed levels of cytotoxicity
too high to consider for co-culture tests. This is due to a 64% reduction in cell
count during one hour of treatment.
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3.2 Effect of DC on the viability of human cells infected with PA01
To determine if we can selectively kill P. aeruginosa in co-coltures, the viability
of human cells infected with PA01 under electric currents and in the presence of
the antibiotic Tobramycin was tested.
The first test was designed to determine the effectiveness of 1.5 µg/mL of
tobramycin with DC treatment on mammalian cells infected with PA01. The cell
lines LC 5908 and LC 5803 were tested with 1.5 µg/mL tobramycin. The two
tests showed less than 1 log killing of bacteria after one hour of DC treatment.
Thus the use of 1.5 µg/mL tobramycin was not sufficient to obtain significant
killing of PA01. This led to a test using 3.0 µg/mL to see if killing would be
achieved with increased tobramycin concentration. As for the mammalian cell
longevity, neither tobramycin concentration showed significant effects on cell
death. To demonstrate the viability of human cells infected with PA01, tests were
set up with cell line LC 5908 and PA01 and treated with 3 µg/mL tobramycin for
one hour of 500 µA DC treatment. After one hour treatment LC 5908 showed a

5% and 12% decrease in viability for the test with and without Tobramycin.
More than two logs of killing was achieved for bacteria in the presence of
tobramycin compared to 1 log killing of bacteria in the absence of tobramycin.
The two tests showed that with the use 3.0 µg/mL there was over two-log killing
of PA01. In contrast, there was less than one log killing with 1.5 µg/mL
tobramycin. Interestingly, the tests run as a control for the 3.0 µg/mL (exclusion
of antibiotic) showed 1 log killing, but the test run as a control for the 1.5 µg/mL
showed no killing. Overall, synergy was observed between 70 µA/cm2 and 3
µg/mL in killing P. aeruginosa PAO1 in co-cultures with Lung Cancer 5908
cells. This condition was found to be safe to human cells.
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Graph 3: A-F show the results of DC treatment on human cells infected
with PA01. A,C,E show bacteria population during treatment. B,D,F
show mammalian cell population during treatment. Tests compared
concentrations of tobramycin.

3.3 Determination of appropriate sonication protocol for 2DE analysis
To better understanding appropriate time and power levels for sonication,
different levels of sonication were tested. The following images show the two
different tests that were run to gain a better understanding of how different levels
of sonication affected the degree of proteins harvested. The first test (Image 4)
showed that the amount of sonication at its maximum of three minutes was still
not enough to obtain results from the supernatant where the proteins should be
found. The images show that as sonication time increase and intensity increased
there were no effects on the amount of protein bands and their respective
densities. This meant that there was a necessity to run the test with the lysis
buffer to help break down the cells before sonication.
Due to this, the next test was designed to use 100% sonication at one minute time
intervals between one and five minutes with 200 µL of lysis buffer. The results
showed that sonication of three, four, and five minutes led to similar results once
lysis buffer was used, whereas, sonication of less than two minutes resulted in less
protein densities in the 1D gels (Image 5). As a conclusion of this experiment,
parameters for the protocol for the variable protein expression mapping due to
electrochemical treatment experiment were set and results were improved.
Finally in Image 6, results for 2D PAGE show how results improve dramatically.
The first image lacks a lot of proteins spots and those that are present are not well
spread out. The second image shows an abundance of protein spots well spread
Out on the gel.
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Image 4: The test results show how varying time and intensity of sonication
affect the amount of protein present in the pellet and supernatant. From left to
right the test shows: (1) Ladder, (2) Supernatant: 75% 2:00 min, (3) Pellet: 75%
1:30 min, (4) Supernatant: 75% 1:30 min, (5) Supernatant: 50% 3:00 min, (6)
Pellet: 50% 3:00 min, (7) Pellet: 50% 2:00 min, (8) Supernatant: 50% 2:00 min,
(9) Pellet: 50% 1:30 min, (10) Supernatant: 50% 1:30 min, (11) Pellet: 75%
2:00 min, (12) Supernatant: 75% 3:00 min, (13) Pellet: 75% 3:00 min, (14)
Supernatant: 100% 1:30 min, (15) Pellet: 100% 1:30 min, (16) Supernatant:
100% 2:00 min, (17) Pellet: 100% 2:00 min, (18) Supernatant: 100% 3:00 min,
(19) Pellet: 100% 3:00 min, and (20) Ladder.
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Image 5:: The test results show how varying time at 100% sonication with
lysis buffer affects the presence of proteins in the supernatant. Times
Tim from
right to left are (1) 1 minute, (2) 3 minutes, (3) 2 minutes, (4) 4 minutes, and
(5) 5 minutes.
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Image 6:: The protein gel
gels show the 2DE gels of P. aeruginosa before (A) and after (B)
optimizing the protocol.
3.4 Differential protein expression P. aeruginosa in response to DC treatment
In order to better understand the mechanism of bacteria killing by DC,
DC protein
expression of P. aeruginosa PAO1 was analyzed using the 2D SDS-PAGE.
SDS
Because the protocol used was designed for Escherichia coli,, eight tests were

done using the technique to ensure that proper and accurate results were achieved.
Further, 1D gel tests were run to examine how varying degrees of intensity at
different time intervals of sonication affected the yield and separation of proteins.
Our results showed that sonication for five minutes at 100% power gave best
results. By comparing 2DE images of the control and DC treated samples of
several proteins, up- or down- regulated by DC were identified. Six represented
proteins were sampled from the gels. Four of them were processed with in-gel
digestion with trypsin and sent to the proteomic facility at Cornell University for
protein identification by sequencing. Protein spot 1 and 3 were found upregulated and extracted from the treated bacteria. Protein spot 1 was identified to
be a 50s ribosomal protein L25 which assists in protein formation, stops peptidyl
hydrolysis, and supports peptide bond formation. Protein spot 3 was found to be a
stress protein, which is expressed in consistent anaerobic conditions due to energy
starvation. Protein spots 4 and 5 were found down-regulated and extracted from
the control bacteria. Protein spot 4 was found to be outer membrane porin F,
which allows for passive diffusion of glucose, nutrients, ions, and water. Protein
spot 5 was found to be DsbA, which is a soluble thiol:disulfide oxidoreductase
periplasmic protein (responsible for froming disulfide bonds in proteins) and
necessary for type III secretion system. Type III secretion system is made of a
protein appendage used to detect eukaryotic cells and influence protein expression
for bacterial infection (proteins are directly secreted into bacteria).

Image 7: The control and treatment gels that show the proteins that were chosen and
extracted for protein identification.

4. Discussion
The application of the bioelectric effect has shown good potential for helping
improve the efficacy of antibiotics for the treatment of chronic infections. This is
especially important for elderly and young persons with weak or under developed
immune systems as well with persons with diseases that decrease the functionality
of their immune system such as HIV and AIDS or cystic fibrosis. The
advancement in understanding the effects of DC treatment on human cells as well
as bacterial cells will help advance this technology against bacteria.
Tests with human cells have shown there to be no majord cytotoxic effects from
the application of DC current at 500 µA (70 µA/cm2) , but the increase of DC
current to 600 µA (84 µA/cm2) was shown to have noticeable effects on human
cells. Thus further experiments with bacteria and tobramycin were centered at
500 µA or 70 µA/cm2.
Follwing the cytotoxicity study, this work progressed to a co-culture model of
human cells and bacterial cells treated together with DC and tobramycin. This
test was important for understanding the effect of DC treatment and antibiotics on
a suspension of PA01 and human cells.
As for the relative cytotoxicity levels of the bioelectric effect, another innovative
idea for the treatment of antibiotic resistant bacteria is through the use of
nanoparticles. The use of the bioelectric effect has some distinct advantages over
nanoparticles. First, the treatment itself does not involve a physical entity that
requires degradation by the body. The use of nanoparticles requires there to be
research into the biocompatibility and mechanical properties of the material.

There are potential issues with how and where nanoparticles would degrade and
what the degraded nanoparticles could cause. One proposed issue is the
accumulation of nanoparticles in intracellular areas leading to organelle disruption
or gene alterations [12]. A study conducted by Pulskamp et. al. found a 60-80%
reduction in cell longevity as a result of the use of carbon nanotubes [13].
The use of the bioelectric effect to control biofilms has been previously studied,
but little has ever been researched and understood about the mechanisms of this
phenomenon. Previous researchers have found efficacy between the uses of
antibiotics with varying electrical currents [17], but the effects on mammalian
cells were not tested. A study by Costerton et. al. suggested that killing of
bacteria is not reliant the generation of ions or antibacterial particles due to the
local electrochemical generation [10]. It has been shown that the stainless steel
oxide film helps maintain the electrodes stability. When breakdown of the oxide
film occurs, passivation occurs, disrupting the oxide film, and leading to
corrosion. This is especially important for applications concerning the bioelectric
effect because oxide films are easily disrupted when the electrical current
becomes too high or too low and as the pH of the environment decreases. This is
not a major issue as the electrodes will only be implanted temporarily, but it is
important that any alloys present on the electrodes be safe in the body as a result
of corrosion of the electrodes [11]. Furthermore, there is potential that the
oxidation and reduction reactions that are occurring could contribute to the
efficacy found between antibiotics and DC treatment. To better understand the
potential that exists to expand upon this, tests will be run to see how higher

antibiotic concentrations continue to reduce the viability of PA01 and if there is a
plateau reached where increased concentrations of the antibiotic have no further
effect.
Results from the co-culture study show the drastic increase in microbial killing as
the concentration of antibiotics is increased from 1.5 µg/mL to 3.0 µg/mL. This
suggests that there may be a threshold concentration of tobramycin for killing
PAO1.
The proteomic results provide new insight into how the bacteria cells are reacting
to DC treatment at the protein level. The 1st spot contained was identified to be a
50s ribosomal protein L25 which assists in protein formation, stops peptidyl
hydrolysis, and supports peptide bond formation. For spot 3, stress proteins were
found. Cells respond to stressful environments by the synthesis of stress proteins
such as the one extracted at spot 1. Stress proteins are synthesized to help with
the stressful environments, but given that the bacteria would have no genetic
information about electrical treatment, the response is probably a standard
response not specific to ec treatment.
Protein spots 4 and 5 were found down-regulated and extracted from the control
bacteria. Protein spot 4 was found to be outer membrane porin F, which allows
for passive diffusion of glucose, nutrients, ions, and water. Protein spot 5 was
found to be DsbA, which is a soluble thiol:disulfide oxidoreductase periplasmic
protein (responsible for froming disulfide bonds in proteins) and necessary for
type III secretion system. Type III secretion system is made of a protein
appendage used to detect eukaryotic cells and influence protein expression for

bacterial infection (proteins are directly secreted into bacteria). These spots show
that the DC treatment is somehow preventing bacteria from infecting human cells
by preventing the formation of the Type III secretion systems. The formation
prevention is not from tobramycin as it was not involved in this test. Also it
appears that since out membrane porin F is down regulated, the bacterium I
working to maintain intracellular homeostasis by preventing the influx of ions,
nutrients, water, and glucose.

Conclusion
In this study, we demonstrated that DC treatment at 70 μA/cm2 is safe to human
cells. Furthermore, the co-culture study showed that DC treatment at 70 μA/cm2
has the ability to selectively kill bacterial cells without causing harm to human
cells. The ffective concentration of tobramycin for co-treatment with DC was
found to be 3.0 µg/mL. To understand the effects of DC on P. aeruginosa at
molecular level, the protocol to harves cellular proteins was optimized to use
sonication with lysis buffer. Upon extraction of proteins and comparison between
control and DC treatment, ADD NAMES proteins were found to be up- and
down- regulated by DC treatment, respectively. Overall, this study provided
important understanding to missing information for bacterial control by DC and
for developing more effective therapies to control chronic infection.
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Capstone Summary
The project set up is entitled “Controlling bacterial persister cells with low
level electric currents.” The project is designed to understand three different
fields related to the study of killing antibiotic resistant bacteria using electrical
currents. The three prongs of the study focus on the potential cytotoxicity of
electrical currents, viability of human cells treated with an infectious bacteria
(Pseudomonas aeruginosa strand PA01), and variable protein expression of PA01
due to the prolonged application of electrical currents. So what does each prong
really mean?
The first study on the cytotoxicity of electrical currents means the study is
designed to measure if using electrical currents on human cells would harm
human cells. If something is cytotoxic it is effectively harmful to the cells. It is
important to note these human cells come from companies and are professionally
and ethically obtained. This is important because if the application of electrical
currents, as a way to treat infectious diseases, which are antibiotic resistant, is
proven effective, it could eventually lead to use in humans as a last resource fight
against bacteria. This study aims to find out whether or not the application of
electrical currents is harmful to individual human cells and the overall human
body longevity. To put it another way, will the application of electrical currents
end up hurting the body more than helping it?
To conduct this portion of the study, different types of cells extracted from
the human body are grown in a solution that helps promote cell longevity. Cells
are grown for a week in a controlled environment before tests are run. The cells

are grown for a week such that approximately the same amounts of cells are being
tested for each testing period. For the tests to be done, cells are put into a cuvette,
which is an upright rectangular container that holds the solution that contains the
suspended human cells. Electrodes are pieces of electrically conductive material
that allow for the flow of electricity from one to another through a nonmetallic
material. By placing two electrodes in a cuvette, on opposite ends, it allows for
the flow of currents from one electrode to the other through the aqueous medium
(human cells suspended in a liquid solution) thus creating an electrical circuit.
This experiment effectively puts human cells in the middle of the current flowing
between these two electrodes. An Ag/AgCl (silver/silver chloride) electrode is
placed between the two electrodes to act as a reference to ensure that the amount
of current flowing between the two electrodes is consistent. The reference acts as
a feedback mechanism by ensuring that the amount of current flowing from one
electrode to the other stays constant. In order to measure whether or not the cells
are being harmed, samples are taken from the cuvette before ec treatment starts
and then after twenty, forty, and sixty minutes have elapsed. Samples are taken
and dyed blue using Trypan blue which serves to dye the cell membrane blue such
that cells are easy to count. To count cells a microscope is used with a specialized
slide that has a grid network on it. The grid network is set up such that there are
four sections of the grid that have a 4x4 grid of squares. By counting the amount
of cells in each of the four sections, an average can be taken and the amount of
cells in the cuvette can be inferred. The reason there are four sections is to ensure
that a good and accurate representation is found. By taking the amount of cells

over the four time intervals (time = 0,20,40,60 minutes), the potential for
cytotoxicity from ec treatment is determined. Results have shown that currents
less than 600 µA have minimal to no cytotoxic effects on the longevity of cells.
The next study is set up to understand how cytotoxicity might be altered
due to the infection and presence of bacteria, Pseudomonas aeruginosa. This
study also aims to see how Pseudomonas aeruginosa react to the ec treatment in
the presence of human cells and with the presence of an antibiotic, tobramycin.
This study is more complicated in that there are more factors involved. The
factors being tested include: will the longevity of human cells be affected with the
presence of bacteria, ec treatment, and antibiotics? Will killing of bacteria occur
with the presence of human cells, ec treatment, and antibiotics? Will killing be
more effective because of variable concentrations of antibiotics?
To answer these questions, a similar technique is used as for the first study
except a specified amount of bacteria and antibiotic is added. The process of
culturing bacteria is done the night before the experiment due to the incredible
rate of bacterial reproduction. Bacteria are grown in a liquids solution or medium
called lysogeny broth (LB), which is high in nutrients. To prepare bacteria for
testing, a set amount of sample is washed with a solution known as a buffer that
rids the LB medium. This is done so that bacteria do not rapidly grow during
testing. To determine how much bacteria there is in the solution a measurement
known as optical density is taken. Optical density is a measure of how much light
is able to pass through a sample at a set wavelength (600nm is used). The amount
of light that is absorbed by the sample correlates to the population of bacteria.

For example, if the goal OD is 0.6 but an OD of 0.9 is measured, you would add
2/3mL sample and 1/3mL buffer instead of 1mL of sample to make your sample
the desired OD. The addition of tobramycin is done at concentrations relative to
studies that have shown an effective range for the antibiotic.
Once the experiment is setup, ec treatment is run. At times of zero,
twenty, forty, and sixty minutes, samples of cells and bacteria are taken and
quantified. The process of quantifying the bacteria is more difficult as it requires
the dilution of the sample to a quantity that can be counted then overnight
culturing so bacteria colonies can grow and be visible for counting. This process
is called plating and tells how the amount of bacteria changes as time passes for
the experiment. With the conclusion of this experiment, information was
determined about the most important concentrations of trobramycin to effectively
kill bacteria alongside ec treatment. This has led to a lot of research being
conducted with my mentor and myself as to why and how ec treatment increases
the efficacy of antibiotics.
The last part of the study focused on understanding why bacteria are dying
due to ec treatment by profiling protein expression. In order to do this, a
technique called 2D- SDS Page was used because it creates a two-dimensional
map of the membrane proteins. The proteins are shown on a gel material and are
separated by the proteins’ relative charges by pH and molecular weight. The
proteins are displayed as black dots of varying size and darkness and can be
extracted and sequenced to determine what specifics proteins are. The process to
create the protein maps takes six days and starts by creating an overnight culture

and running ec treatment. After ec treatment the cells are broken apart by a lysis
buffer then DNA, RNA, and cell membrane fragments are broken up by a
machine called a sonicator. The sonicator works by applying sound energy to
samples disrupting genetic material so it does not remain in the mixture and alter
results. After this, the proteins are put onto a one dimension gel strip and
separated by pH gradient using a 24hr period of applied voltage. Protein
interactions are disrupted so that proteins do not attach to each other preventing
clear results. The last step involves the creation of gels then putting the one
dimension gel strip on top and allowing it to run to create a two dimensional map
of the process which shows the expression of proteins. For this study, an
experimental (ec treated bacteria) and a control test (not ec treated bacteria)
showed how the protein expression of the bacteria changed. By extracting
proteins that changed in concentrations between the two tests, information about
how different membrane proteins are in higher and lower concentrations will
provide insight into how the bacteria are reacting to ec treatment.
The importance of this study is to examine new and innovative ways to
kill antibiotic resistance bacteria that are becoming increasingly prominent. This
problem has seen rise in many hospital settings where there is a constant need to
eradicate the presence of any potentially harmful bacteria. The specific strand of
bacteria tested, Pseudomonas aeruginosa, has been found to be resistant to
multiple strands of antibiotics already. P. aeruginosa is an opportunistic
bacterium that leads to skin infections, issues with cystic fibrosis, and elderly
patients with weakened immune systems. P. aeruginosa can also lead to the

formation of biofilms in nature and in hospital settings on implants. Biofilms are
communities of bacteria that attach to a surface in grow within an extracellular
polymeric surface (EPS) that protects the bacteria from antibiotics and harmful
environments until the biofilm bursts and releases the bacteria. Biofilms are
especially a problem as they allow for bacteria to trade genes that allow for
widespread resistance to antibiotics. Another potential source of antibiotic
resistant bacteria is persister cells. Persister cells are dormant cells that are
practically metabolically inactive when a patient is taking their antibiotics, but
become active again after the antibiotic regime is over and are able to repopulate
and cause the symptoms to arise again (this is why it is very important to take
antibiotics to completion!). When bacteria are able to repopulate and cause an
infection to come back there is a better chance for the bacteria to learn antibiotic
resistance and cause potentially life threatening issues to the patients.
Many approaches are being examined to find ways to overcome issues
involved with antibiotic resistance, but the focus of this study is to learn more
about the use of the bioelectric effect. The bioelectric effect aims to treat bacteria
with antibiotics and electrical currents in order to increase the efficiency of the
antibiotics. The project has helped prove that no harmful effects have been shown
by using the bioelectric effect on varying strands of human cells. In addition, the
study has delved into the level of electrical current applied and the amount of
antibiotic used to maximize killing of bacteria while ensuring the longevity of
human cells. The future of the bioelectric effect is looking into how the use of
electrical currents helps improve efficacy of antibiotics by examining how the

antibiotics are transported into the cell. In addition, a sinus infection will be
induced on an animal model to test how an actual animal reacts to DC treatment.

